NewTimeSpace News, May 8,Adventus Holdings disclosed in an announcement that the power system disruption at the Group's hotel property in Da Nang, Vietnam, has been resolved.
NewTimeSpace News, May 8，USP Group, which is currently under judicial management, disclosed in an announcement that it has filed an application with the High Court to extend the judicial management period, seeking to extend the judicial management and the appointment of the Judicial Managers until July 17, 2026, or the date of the final determination of OA 472, whichever is later.
NewTimeSpace News, May 8,Wilmar International disclosed that a Russian court on May 5, 2026, ordered the seizure of Vadim Moshkovich's interest in Rusagro, including a 24% interest in JSC Etalon held by Profit, which is indirectly owned by Wilmar International.
NewTimeSpace News, May 8,Autagco disclosed in an announcement that it has completed a share consolidation on the basis of every two existing ordinary shares consolidated into one share, effective from 9:00 a.m. on May 8, 2026.
NewTimeSpace News, May 8,Mapletree Industrial Trust disclosed in an announcement that the Trustee-Manager, Mapletree Industrial Trust Management Ltd., was issued 816,400 new units at S$1.9613 per unit on the same day for the payment of the Manager's base fee.
NewTimeSpace News, May 8,SDAI Limited disclosed that its wholly-owned subsidiary, SDAI Healthcare Pte. Ltd., has entered into a cooperation agreement with LiveBeyond Pte. Ltd. LiveBeyond will provide strategic and scientific consultancy services to support the Group's commercialisation of longevity-related products, as well as scientific advisory and market credibility endorsement.
NewTimeSpace News, May 8,TSH Resources disclosed in an announcement that the company repurchased 60000 shares on May 8, with a minimum purchase price of MYR 1.31 per share and a maximum of MYR 1.32 per share, for a total consideration of approximately MYR 78800.
NewTimeSpace News, May 8,Rex International Holding disclosed in an announcement that, as the majority of the board members of Lime Petroleum Holding AS (LPH) have been changed to independent third parties, the Company no longer has director representation on the new boards of LPH and LPA.
NewTimeSpace News, May 8,HRnetGroup announced that it sold 250,000 treasury shares on May 8, 2026, with a sale value of approximately S$183,250.
NewTimeSpace News, May 8,JUMBO Group announced the declaration of an interim tax-exempt (one-tier) dividend of S$0.005 per ordinary share for the financial year ending September 30, 2026.
NewTimeSpace News, May 8,Keppel DC REIT confirmed in an announcement that a fire occurred on the morning of May 7, 2026 (CET) in the technical room of its Almere Data Centre in the Netherlands. The technical room is separate from the data halls.
NewTimeSpace News, May 8,Octopus (APAC) Holdings disclosed in an announcement that its application for an extension of time to comply with Catalist listing rules (including the issuance of annual reports) for the financial year ended March 31, 2026, has been rejected by Singapore Exchange Regulation (SGX RegCo). The Company stated that it intends to file an appeal and will update shareholders on further developments in due course.
NewTimeSpace News, May 8,Interra Resources disclosed in an announcement that its joint operating company, Frontier Interra Solar Energy Co., Ltd. (JOC), has entered into a rooftop solar system agreement with the Air Support Division of the Border Patrol Police in Thailand.
NewTimeSpace News, May 9,EC World REIT disclosed in an announcement that its subsidiary, Hangzhou Beigang Logistics Co., Ltd. ("Beigang"), and other entities have been sued by Hangzhou Fenhua Investment LLP (an affiliate of China Zheshang Bank). The Hangzhou Intermediate Court ruled on May 6, 2026, that Beigang and the other defendants are jointly liable for a total amount of approximately RMB 3.515 billion.
NewTimeSpace News: Jiangsu Hengrui Pharmaceutical Co., Ltd. (01276.HK) announced that the Company and its subsidiaries have received Notices of Approval for Clinical Trials from the NMPA for five drugs, including HRS-6093 Tablets, SHR-9839 (sc) for Injection, SHR-1826 for Injection, Adebrelimab Injection, and SHR-8068 Injection. These drugs will be jointly evaluated in clinical trials for advanced malignant solid tumors with KRAS G12D mutation.Among them, HRS-6093 Tablets are a novel KRAS G12D inhibitor, with no similar products approved globally yet.
NewTimeSpace News: Jiangsu Hengrui Pharmaceutical Co., Ltd. (01276.HK) announced that it has received the Notice of Approval for Clinical Trials for HRS-3005 Tablets issued by the NMPA, approving clinical trials of the product for B-cell malignancies. HRS-3005 Tablets are an innovative anti-tumor drug independently developed by the Company. No similar drugs have been approved for marketing globally to date, with accumulated R&D investment of approximately RMB 26.2 million.
